TransMedics Group (TMDX) PT Lowered to $65 at Stifel
Tweet
Share
E-mailGet Alerts TMDX Hot Sheet
Price: $90.85 -3.32%
Rating Summary:
11 Buy, 5 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 12 | Down: 15 | New: 40
Rating Summary:
11 Buy, 5 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 12 | Down: 15 | New: 40
Join SI Premium – FREE
Stifel analyst Thomas Stephan lowered the price target on TransMedics Group (NASDAQ: TMDX) to $65.00 (from $80.00) while maintaining a Hold rating.
You May Also Be Interested In
- NRW Holdings Ltd. (NWH:AU) PT Raised to AUD8.47 at Canaccord
- Unicycive Therapeutics (UNCY) PT Raised to $15 at Benchmark Following Q2 Results
- Rubrik Inc (RBRK) PT Raised to $120 at Oppenheimer; Sees Another 'Beat and Raise'
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
